Location Vancouver, British Columbia, Canada Gender Male Also Known As Dan
LinkedIn View on LinkedIn
Biotechnology entrepreneur and commercial leader. Previously co-founder and CEO of ImStar Therapeutics, leveraging RNA biology to discover novel treatments for ALS and neurodegenerative diseases. Also co-founder and CEO of Valocor Therapeutics. Led that company from inception until its merger with Dermira, Inc. (Nasdaq: DERM). Dermira was acquired
in 2020 by Lilly for $1.1B. 25+ years commercial leadership experience in the biotech and pharmaceutical industries. Notably, was responsible for the US commercial launch of Remicade, which was ultimately acquired by Johnson & Johnson and reached over $10B in annual sales worldwide.
